Proteomics Analysis of Immunoprecipitated Proteins Associated with the Oncogenic Kinase Cot

  • Wu, Binhui (School of Biological Sciences, Nanyang Technological University) ;
  • Wilmouth, Rupert C. (School of Biological Sciences, Nanyang Technological University)
  • Received : 2007.04.09
  • Accepted : 2007.08.09
  • Published : 2008.02.29

Abstract

Cancer Osaka thyroid, also known as Tpl-2 (Cot) is a member of the MAP3K kinase family and plays a key role in the regulation of the immune response to pro-inflammatory stimuli such as lipopolysaccharide (LPS) and tumour necrosis $factor-{\alpha}$ ($TNF-{\alpha}$). A series of Cot constructs with an N-terminal 6xHis tag were transiently expressed in HEK293 cells: $Cot_{130-399}$ (kinase domain), $Cot_{1-388}$ (N-terminal and kinase do-mains), $Cot_{1-413}$, $Cot_{1-438}$ (containing a putative PEST sequence), $Cot_{1-457}$ (containing both PEST and degron sequences) and $Cot_{1-467}$ (full-length protein). These Cot proteins were pulled down using an anti-6xHis antibody and separated by 2D electrophoresis. The gels were silver-stained and 21 proteins were detected that did not appear, or had substantially reduced intensity, in the control sample. Three of these were identified by MS and MS/MS analysis as Hsp90, Hsp70 and Grp78. Hsp90 appeared to bind to the kinase domain of Cot and this interaction was further investigated using co-immuno-precipitation with both overexpressed Cot in HEK293 cells and endogenous Cot in Hela cells.

Keywords

Chaperone;Cot;Hsp90;MAP3K

Acknowledgement

Supported by : Nanyang Technological University

References

  1. Erny, K.M., Peli, J., Lambert, J.F., Muller, V., and Diggelmann, H. (1996). Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis. Oncogene 13, 2015-2020
  2. Kane, L.P., Mollenauer, M.N., Xu, Z., Turck, C.W., and Weiss, A. (2002). Akt-dependent phosphorylation specifically regulates Cot induction of NF-$\kappa$B-dependent transcription. Mol. Cell. Biol. 22, 5962-5974 https://doi.org/10.1128/MCB.22.16.5962-5974.2002
  3. Salmeron, A., Ahmad, T.B., Carlile, G.W., Pappin, D., Narsimhan, R.P., and Ley, S.C. (1996). Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15, 817-826
  4. Tsatsanis, C., Patriotis, C., Bear, S.E., and Tsichlis, P.N. (1998). The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines. Proc. Natl. Acad. Sci. USA 95, 3827-3832
  5. Stancato, L.F., Chow, Y.H., Hutchison, K.A., Perdew, G.H., Jove, R., and Pratt, W.B. (1993). Raf exists in a native heterocomplex with hsp90 and p50 that can be reconstituted in a cell-free system. J. Biol. Chem. 268, 21711-21716
  6. Vercauteren, F.G., Arckens, L., and Quirion, R. (2006). Applications and current challenges of proteomic approaches, focusing on two-dimensional electrophoresis. Amino Acids 33, 405-414 https://doi.org/10.1007/s00726-006-0460-5
  7. Broemer, M., Krappman, D., and Scheidereit, C. (2004). Requirement of Hsp90 activity for I$\kappa$B kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-$\kappa$B activation. Oncogene 23, 5378-5386 https://doi.org/10.1038/sj.onc.1207705
  8. Chiariello, M., Marinissen, M.J., and Gutkind, J.S. (2000). Multiple mitogen-activated protein kinase signaling pathways connect the Cot oncoprotein to the c-jun promoter and to cellular transformation. Mol. Cell. Biol. 20, 1747-1758 https://doi.org/10.1128/MCB.20.5.1747-1758.2000
  9. Aoki, M., Hamada, F., Sugimoto, T., Sumida, S., Akiyama, T., and Toyoshima, K. (1993). The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation. J. Biol. Chem. 268, 22723-22732
  10. Caivano, M., Rodriguez, C., Cohen, P., and Alemany, S. (2003). 15-Deoxy-$\Delta^{12,14}$-prostaglandin $J_{2}$ regulates endogenous Cot MAPK kinase kinase 1 activity induced by lipopolysaccharide. J. Biol. Chem. 278, 52124-52130 https://doi.org/10.1074/jbc.M306583200
  11. Lin, X., Cunningham, E.T., Mu, Y., Geleziunas, R., and Greene, W.C. (1999). The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kB acting through the NF-kB-inducing kinase and IkB kinases. Immunity 10, 271-280 https://doi.org/10.1016/S1074-7613(00)80027-8
  12. Barati, M.T., Rane, M.J., Klein, J.B., and McLeish, K.R. (2006). A proteomic screen identified stress-induced chaperone proteins as targets of Akt phosphorylation in mesangial cells. J. Proteome Res. 5, 1636-1646 https://doi.org/10.1021/pr0502469
  13. Ceci, J.D., Patriotis, C.P., Tsatsanis, C., Makris, A.M., Kovatch, R., Swing, D.A., Jenkins, N.A., Tsichlis, P.N., and Copeland, N.G. (1997). Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev. 11, 688-700 https://doi.org/10.1101/gad.11.6.688
  14. Beinke, S., Deka, J., Lang, V., Belich, M.P., Walker, P.A., Howell, S., Smerdon, S.J., Gamblin, S.J., and Ley, S.C. (2003). NF-${\kappa}B1$ p105 negatively regulates TPL-2 MEK kinase activity. Mol. Cell. Biol. 23, 4739-4752 https://doi.org/10.1128/MCB.23.14.4739-4752.2003
  15. Lang, V., Symons, A., Watton, S.J., Janzen, J., Soneji, Y., Beinke, S., Howell, S., and Ley, S.C. (2004). ABIN-2 forms a ternary complex with TPL-2 and NF-$\kappa$B1 p105 and is essential for TPL-2 protein stability. Mol. Cell. Biol. 24, 5235-5248 https://doi.org/10.1128/MCB.24.12.5235-5248.2004
  16. Sourvinos, G., Tsatsanis, C., and Spandidos, D.A. (1999). Over-expression of the Tpl-2/Cot oncogene in human breast cancer. Oncogene 18, 4968-4973 https://doi.org/10.1038/sj.onc.1202891
  17. Makris, A., Patriotis, C., Bear, S.E., and Tsichlis, P.N. (1993). Genomic organization and expression of Tpl-2 in normal cells and Moloney murine leukemia virus-induced rat T-cell lymphomas: activation by provirus insertion. J. Virol. 67, 4283-4289
  18. Pratt, W.B. and Toft, D.O. (2003). Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. 228, 111-133
  19. Mayer, M.P. and Bukau, B. (1998). Hsp70 chaperone systems: diversity of cellular functions and mechanism of action. Biol. Chem. 379, 261-268
  20. Prince, T. and Matts, R.L. (2004). Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37. J. Biol. Chem. 279, 39975-39981 https://doi.org/10.1074/jbc.M406882200
  21. Cullinan, S.B. and Whitesell, L. (2006). Heat shock protein 90: a unique chemotherapeutic target. Semin. Oncol. 33, 457-465
  22. Das, S., Cho, J., Lambertz, I., Kelliher, M.A., Eliopoulos, A.G., Du, K., and Tsichlis, P. N. (2005). Tpl2/Cot signals activate ERK, JNK, and NF-$\kappa$B in a cell-type and stimulus-specific manner. J. Biol. Chem. 280, 23748-23757 https://doi.org/10.1074/jbc.M412837200
  23. Sato, S., Fujita, N., and Tsuruo, T. (2000). Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl. Acad. Sci. USA 97, 10832-10837
  24. Gandara, M.L., Lopez, P., Hernando, R., Castano, J.G., and Alemany, S. (2003). The COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity. Mol. Cell. Biol. 23, 7377-7390 https://doi.org/10.1128/MCB.23.20.7377-7390.2003
  25. Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J.H., Patriotis, C., Jenkins, N.A., Copeland, N.G., Kollias, G., et al. (2000). TNF-$\alpha$ induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071-1083 https://doi.org/10.1016/S0092-8674(00)00210-5